1.Shen J, Cao B, Wang Y, Xiao A, Qin J, Wu J, Yan Q, Hu Y, Yang C, Cao Z, Hu J, Yin P, Xie D, Gong J. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2?+?CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial. Trials. 2018 Aug 9;19(1):432. doi: 10.1186/s13063-018-2790-5.
2.Shen J, Cao B, Wang Y, Ma C, Zeng Z, Liu L, Li X, Tao D, Gong J, Xie D. Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer. J Exp Clin Cancer Res. 2018 Jul 28;37(1):175. doi: 10.1186/s13046-018-0850-z.
3.Xie D, Wang Y, Shen J, Hu J, Yin P, Gong J. Detection of carcinoembrionic antigen in peritoneal fluid of patients undergoing laparoscopic distal gastrectomy with complete mesogastric excision. British Journal of Surgery. 2018; DOI:10.1002/bjs.10881.
4.Xie D, Yu C, Gao C, Osaiweran H, Hu J, Gong J. An Optimal Approach for Laparoscopic D3 Lymphadenectomy Plus Complete Mesocolic Excision (D3+CME) for Right-Sided Colon Cancer. Ann Surg Oncol. 2017;24(5):1312-1313.
5.Shen J, Xie D, Tong Y, Gong J. The length and complexity of mesentery are related to the locoregional recurrence of the carcinoma in gut. Med Hypotheses. 2017 Jun;103:133-135. doi: 10.1016/j.mehy.2017.04.013.
6.Luo XL, Xie DX, Wu JX, Wu AD, Ge ZQ, Li HJ, Hu JB, Cao ZX, Gong JP. Detection of metastatic cancer cells in mesentery of colorectal cancer patients. World J Gastroenterol. 2017; 23(34):6315-6320.
7.Xie D, Yu C, Liu L, Osaiweran H, Gao C, Hu J, Gong J. Short-term outcomes of laparoscopic D2 lymphadenectomy with complete mesogastrium excision for advanced gastric cancer. Surgical Endoscopy. 2016;30(11):5138-5139.
8.Liu L, Xu C, Hsieh JT, Gong J, Xie D. DAB2IP in cancer. Oncotarget. 2016;26;7(4):3766-76.
9.Min J, Liu L, Li X, Jiang J, Wang J, Zhang B, Cao D, Yu D, Tao D, Hu J, Gong J, Xie D. Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancer. Sci Rep. 2015;5:16578. doi: 10.1038/srep16578.
10.Xie D, Liu L, Osaiweran H, Yu C, Sheng F, Gao C, Hu J, Gong J. Detection and Characterization of Metastatic Cancer Cells in the Mesogastrium of Gastric Cancer Patients. PLoS One. 2015;13;10(11):e0142970. 
11.Xie D, Gao C, Lu A, Liu L, Yu C, Hu J, Gong J. Proximal segmentation of the dorsal mesogastrium reveals new anatomical implications for laparoscopic surgery. Sci. Rep. 2015;5:16287. doi: 10.1038/srep16287. 
12.Wu K, Liu J, Tseng SF, Gore C, Ning Z, Sharifi N, Fazli L, Gleave M, Kapur P, Xiao G, Sun X, Oz OK, Min W, Alexandrakis G, Yang CR, Hsieh CL, Wu HC, He D, Xie D（*）, and Hsieh JT（*）. The role of DAB2IP in androgen receptor activation during prostate cancer progression. Oncogene. 2014;33(15):1954-63.
13.Wu K, Xie D, Zou Y, Zhang T, Pong RC, Xiao G, Fazli L, Gleave M, He D, Boothman DA, and Hsieh JT. The mechanism of DAB2IP in chemoresistance of prostate cancer cells. Clinical cancer research. 2013;19(17):4740-9 
14.Xie D, Osaiweran H, Liu L, Wang X, Yu C, Tong Y, Hu J, and Gong J. Mesogastrium: a fifth route of metastasis in gastric cancer? Medical hypotheses. 2013;80(4):498-500 
15.Min J, Wang X, Tong Y, Li X, Tao D, Hu J, Xie D（*）, and Gong J（*）. Expression of cyclins in high-density cultured cells and in vivo tumor cells. Cytometry Part A : the journal of the International Society for Analytical Cytology. 2012;81(10):874-82. 
16.Xie D, Gore C, Liu J, Pong RC, Mason R, Hao G, Long M, Kabbani W, Yu L, Zhang H, Chen H, Sun X, Boothman DA, Min W, and Hsieh JT. Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(6):2485-90. 
17.Xie D, Gore C, Zhou J, Pong RC, Zhang H, Yu L, Vessella RL, Min W, and Hsieh JT. DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis. Proceedings of the National Academy of Sciences of the United States of America. 2009;106(47):19878-83. 
18.Kong Z, Xie D, Boike T, Raghavan P, Burma S, Chen DJ, Habib AA, Chakraborty A, Hsieh JT, and Saha D. Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation. Cancer research. 2010;70(7):2829-39.
19.Xie DX, Yao J, Zhang P, Li XL, Feng YD, Wu JH, Tao DD, Hu JB, and Gong JP. Are progenitor cells pre-programmed for sequential cell cycles not requiring cyclins D and E and activation of Cdk2? Cell proliferation. 2008;41(2):265-78.